Department of Pharmacology, Faculty of Pharmacy, Ankara University, 06100, Tandogan, Ankara, Turkey.
Department of Pharmacology, Faculty of Pharmacy, Bezmialem Vakif University, Fatih, 34093, Istanbul, Turkey.
Mol Cell Biochem. 2018 Sep;446(1-2):149-160. doi: 10.1007/s11010-018-3282-3. Epub 2018 Jan 23.
β-Adrenoceptors (AR) stimulate cardiac Na/K pump in healthy hearts. β-ARs are upregulated by persistent sympathetic hyperactivity; however, their effect on Na/K ATPase activity and ventricular function in this condition is still unknown. Here, we investigate preventive effects of additional β-AR activation (BRL) on Na/K ATPase activity and in vivo hemodynamics in a model of noradrenaline-induced hypertrophy. Rats received NA or NA plus simultaneously administered BRL in vivo infusion for 14 days; their cardiac function was investigated by left ventricular pressure-volume analysis. Moreover, fibrosis and apoptosis were also assessed histologically. NA induced an hypertrophic pattern, as detected by morphological, histological, and biochemical markers. Additional BRL exposure reversed the hypertrophic pattern and restored Na/K ATPase activity. NA treatment increased systolic function and depressed diastolic function (slowed relaxation). Additional BRL treatment reversed most NA-induced hemodynamic changes. NA decreased Na/K pump α2 subunit expression selectively, a change also reversed by additional BRL treatment. Increasing β-AR stimulation may prevent the consequences of chronic NA exposure on Na/K pump and in vivo hemodynamics. β-AR agonism may thus represent a new therapeutic strategy for pharmacological modulation of hypertrophy under conditions of chronically enhanced sympathetic activity.
β-肾上腺素受体 (AR) 可刺激健康心脏中的心肌 Na/K 泵。β-AR 可被持续的交感神经活性上调;然而,其在这种情况下对 Na/K ATP 酶活性和心室功能的影响仍不清楚。在这里,我们研究了在去甲肾上腺素诱导的肥厚模型中,额外的β-AR 激活(BRL)对 Na/K ATP 酶活性和体内血液动力学的预防作用。大鼠接受体内输注去甲肾上腺素或去甲肾上腺素加同时给予的 BRL 14 天;通过左心室压力-容积分析研究其心功能。此外,还通过组织学评估纤维化和细胞凋亡。NA 诱导了形态学、组织学和生化标志物检测到的肥厚模式。额外的 BRL 暴露逆转了肥厚模式并恢复了 Na/K ATP 酶活性。NA 治疗增加了收缩功能并降低了舒张功能(舒张减慢)。额外的 BRL 治疗逆转了大多数由 NA 引起的血液动力学变化。NA 选择性降低 Na/K 泵 α2 亚基的表达,这种变化也被额外的 BRL 治疗逆转。增加β-AR 刺激可能会防止慢性 NA 暴露对 Na/K 泵和体内血液动力学的影响。因此,β-AR 激动剂可能代表一种在慢性增强的交感神经活性条件下对肥厚进行药理学调节的新治疗策略。